CD19 and neoplasm: Furthermore, an in vitro investigation confirmed that CD19-CAR T-cells increased cytotoxic effect against two different cancer cell lines. Finally, they discovered that delivering CD19 to cancer cells could enhance CAR T-cells efficacy against tumor cells that displayed low amounts of antigen, indicating that it may be used to address antigen low evasion [156].